Fundraising September 15, 2024 – October 1, 2024 About fundraising

Combined Erlotinib and PF-03084014 treatment contributes to...

  • Main
  • 2017 / 12
  • Combined Erlotinib and PF-03084014 treatment contributes to...

Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma

Zheng, Yang, Wang, Zhao, Ding, Xu, Dong, Yibo, Zhang, Wei, Zhang, Wei, Zhong, Yi, Gu, Wenyi, Wu, Yunong, Song, Xiaomeng
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cell Proliferation
DOI:
10.1111/cpr.12424
Date:
December, 2017
File:
PDF, 1.52 MB
english, 2017
Conversion to is in progress
Conversion to is failed